![Scott Stromatt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott Stromatt
Keine laufenden Positionen mehr
Profil
Scott C.
Stromatt worked as a Director of Medical Affairs at G.D.
Searle & Co., Inc. and as a Vice President of Clinical Research at Synergen, Inc. He was also the EVP of Clinical Development & Regulatory Affairs at CTI BioPharma Corp.
and the Chief Medical Officer & VP of Clinical Research at Northwest Biotherapeutics, Inc. He served as the Senior Vice President at C.E.
Unterberg, Towbin Holdings, Inc. and as the Chief Medical Officer & Senior Vice President at Emergent Product Development Seattle and Emergent BioSolutions, Inc. He was also the Chief Medical Officer & SVP of Clinical Development at Aptevo Therapeutics, Inc. Dr. Stromatt earned a doctorate degree from The University of Chicago and an undergraduate degree and an MBA from The University of Colorado.
Ehemalige bekannte Positionen von Scott Stromatt
| Unternehmen | Position | Ende |
|---|---|---|
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2016 |
| CTI BIOPHARMA CORP. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2008 |
| NORTHWEST BIOTHERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 02.10.2003 |
C. E. Unterberg, Towbin, Inc.
 C. E. Unterberg, Towbin, Inc. Investment Banks/BrokersFinance Provides investment bank services in the technology, healthcare, and security/crime control/anti-terrorism industries | Analyst-Equity | 18.02.2002 |
| APTEVO THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Scott Stromatt
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
34
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Synergen, Inc.
 Synergen, Inc. Electric UtilitiesUtilities Distributes electricity | Utilities |
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
Northwest Biotherapeutics, Inc.
 Northwest Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes immunotherapy products | Health Technology |
C.E. Unterberg, Towbin Holdings, Inc.
 C.E. Unterberg, Towbin Holdings, Inc. Investment ManagersFinance Provides financial advisory services | Finance |
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical products | Health Technology |
G.D. Searle & Co., Inc.
 G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries Makes diversified line of chemicals and agricultural products | Process Industries |
C. E. Unterberg, Towbin, Inc.
C. E. Unterberg, Towbin, Inc. Investment Banks/BrokersFinance Provides investment bank services in the technology, healthcare, and security/crime control/anti-terrorism industries | Finance |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Colorado
 The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emergent BioSolutions, Inc.
 Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Aptevo Therapeutics, Inc.
 Aptevo Therapeutics, Inc. BiotechnologyHealth Technology Provides immunology and cancer research services | Health Technology |
